On Wednesday, UBS raised its price target for Ambev (NYSE:ABEV) from $2.60 to $2.70, while maintaining a Neutral rating on the shares. This adjustment reflects UBS’s updated analysis of the company’s market position and prospects.
A close-up on several cans of freshly brewed beer in a commercial brewery.
Ambev released its Q1 2025 key business developments on May 8 and reported a high single-digit increase in top-line revenue, with volume growth of 0.7%, achieving an all-time high for the first quarter. Net revenue per hectoliter increased by ~6%. Despite a tough comparison due to a one-off tax benefit in the previous year, net income was virtually flat, with normalized net income at BRL 3.8 billion. Cash flow from operating activities increased by 68% year-on-year to BRL 1.2 billion.
Ambev also saw growth in digital transactions, with GMV increasing by 60% and DTC orders rising by 5%. The company maintained a stable market share in key regions such as Brazil and Argentina, with strong performances from premium and non-alcoholic beer segments. However, the company anticipates foreign exchange/FX and commodities pressure starting in Q2 2025, which could hinder margin expansion efforts.
Ambev produces, distributes, and sells beer, draft beer, carbonated soft drinks, malt & food, other alcoholic beverages, and non-alcoholic & non-carbonated products in Brazil, Central America & Caribbean, Latin America South, and Canada.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
